Markus P Arnold1, Jacob G Calcei2, Nicole Vogel1, Robert A Magnussen3, Mark Clatworthy4, Tim Spalding5, John D Campbell6, John A Bergfeld7, Seth L Sherman8. 1. Practice LEONARDO, Hirslanden Clinic Birshof, Münchenstein, Switzerland. 2. Department of Orthopaedic Surgery, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA. 3. Department of Orthopaedic Surgery, The Ohio State University, Columbus, OH, USA. 4. Department of Orthopaedics, Middlemore Hospital, Otahuhu, Auckland, New Zealand. 5. Department of Orthopaedics, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK. 6. Bridger Orthopedics and Sports Medicine, PC, Montana State University, Bozeman, MT, USA. 7. Department of Orthopaedic Surgery, The Cleveland Clinic Foundation, Cleveland, OH, USA. 8. Department of Orthopaedic Surgery, Stanford University Medical Center, Palo Alto, CA, USA. shermans@stanford.edu.
Abstract
PURPOSE: Anterior cruciate ligament reconstruction (ACLR) aims to restore knee function and stability, allowing patients to return to the activities they enjoy and minimize further injury to the meniscus and cartilage and their ultimate progression to osteoarthritis. This study aims to present the evolution of graft choice over the last three decades according to members of the ACL Study Group (SG). METHODS: Prior to the January 2020 ACL SG biannual meeting, a survey was administered consisting of 87 questions and 16 categories, including ACLR graft choice. A similar questionnaire has been administered prior to each meeting and survey results from the past 14 meetings (1992 through 2020, excluding 1994) are included in this work. Survey responses are reported as frequencies in percentages to quantify changes in practice over the surgery period. RESULTS: In 1992, the most frequent graft choice for primary ACLR was bone-patellar tendon-bone (BTB) autograft, at nearly 90%. Hamstring tendon (HT) autografts have increased in popularity, currently over 50%, followed by just under 40% BTB autograft. Recently, quadriceps tendon (QT) autograft has increased in popularity since 2014. CONCLUSION: Autograft (HT, BTB, QT) is an overwhelming favorite for primary ACLR over allograft. The preference for HT autograft increased over the study period relative to BTB autograft, with QT autograft gaining in popularity in recent years. Graft selection should be individualized for each patient and understanding the global trends in graft choice can help orthopaedic surgeons discuss graft options with their patients and determine the appropriate graft for each case. LEVEL OF EVIDENCE: Level V, Expert Opinion.
PURPOSE: Anterior cruciate ligament reconstruction (ACLR) aims to restore knee function and stability, allowing patients to return to the activities they enjoy and minimize further injury to the meniscus and cartilage and their ultimate progression to osteoarthritis. This study aims to present the evolution of graft choice over the last three decades according to members of the ACL Study Group (SG). METHODS: Prior to the January 2020 ACL SG biannual meeting, a survey was administered consisting of 87 questions and 16 categories, including ACLR graft choice. A similar questionnaire has been administered prior to each meeting and survey results from the past 14 meetings (1992 through 2020, excluding 1994) are included in this work. Survey responses are reported as frequencies in percentages to quantify changes in practice over the surgery period. RESULTS: In 1992, the most frequent graft choice for primary ACLR was bone-patellar tendon-bone (BTB) autograft, at nearly 90%. Hamstring tendon (HT) autografts have increased in popularity, currently over 50%, followed by just under 40% BTB autograft. Recently, quadriceps tendon (QT) autograft has increased in popularity since 2014. CONCLUSION: Autograft (HT, BTB, QT) is an overwhelming favorite for primary ACLR over allograft. The preference for HT autograft increased over the study period relative to BTB autograft, with QT autograft gaining in popularity in recent years. Graft selection should be individualized for each patient and understanding the global trends in graft choice can help orthopaedic surgeons discuss graft options with their patients and determine the appropriate graft for each case. LEVEL OF EVIDENCE: Level V, Expert Opinion.
Authors: Etienne Cavaignac; Benoit Coulin; Philippe Tscholl; Nik Nik Mohd Fatmy; Victoria Duthon; Jacques Menetrey Journal: Am J Sports Med Date: 2017-03-08 Impact factor: 6.202
Authors: Austin M Barrett; Jason A Craft; William H Replogle; Josie M Hydrick; Gene R Barrett Journal: Am J Sports Med Date: 2011-07-22 Impact factor: 6.202
Authors: Robert H Brophy; Leah Schmitz; Rick W Wright; Warren R Dunn; Richard D Parker; Jack T Andrish; Eric C McCarty; Kurt P Spindler Journal: Am J Sports Med Date: 2012-09-21 Impact factor: 6.202
Authors: Haukur Björnsson; Kristian Samuelsson; David Sundemo; Neel Desai; Ninni Sernert; Lars Rostgård-Christensen; Jón Karlsson; Jüri Kartus Journal: Am J Sports Med Date: 2016-05-26 Impact factor: 6.202
Authors: Michael J Anderson; William M Browning; Christopher E Urband; Melissa A Kluczynski; Leslie J Bisson Journal: Orthop J Sports Med Date: 2016-03-15
Authors: Michael-Alexander Malahias; Francesco Maria Capece; Claudio Ballarati; Marco Viganò; Marco Marano; Marcus Hofbauer; Danilo Togninalli; Laura de Girolamo; Matteo Denti Journal: Knee Surg Sports Traumatol Arthrosc Date: 2022-01-18 Impact factor: 4.342
Authors: Volker Musahl; Ian D Engler; Ehab M Nazzal; Jonathan F Dalton; Gian Andrea Lucidi; Jonathan D Hughes; Stefano Zaffagnini; Francesco Della Villa; James J Irrgang; Freddie H Fu; Jon Karlsson Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-12-05 Impact factor: 4.342
Authors: Hayden P Baker; Sarah Bhattacharjee; Charles Poff; Collin Bartolotta; Aravind Athiviraham Journal: Arthrosc Sports Med Rehabil Date: 2022-06-24
Authors: Stefano Di Paolo; Piero Agostinone; Alberto Grassi; Gian Andrea Lucidi; Erika Pinelli; Marco Bontempi; Gregorio Marchiori; Laura Bragonzoni; Stefano Zaffagnini Journal: Orthop J Sports Med Date: 2021-07-15